retatrutide for obesity VisualAbstract: reduces body weight by 17.5% in patients with Retatrutide for weight loss: Study

Answer: Semaglutide targets one receptor (GLP-1), tirzepatide targets two (GLP-1 and GIP), and retatrutide targets three (GLP-1, GIP, and glucagon)

Drucker DJ, Shi Q, Crivici A, Sumner-Smith M, Tavares W, Hill M, et al

However, it must be stated that any possible beneficial liver effects of both SGLT2 inhibitors and GLP-1R agonists beyond weight loss are awaiting definitive proof in future mechanistic clinical studies [141, 142]

Prescription A licensed provider reviews your intake and prescribes treatment if eligible

GLP-1 drugs have been linked to an increased risk of gallbladder disease, including gallstones and cholecystitis

[DOI] [PubMed] [Google Scholar] 64.Ayoub WA, et al